ADVA Biotechnology is focused on developing and selling enabling technologies for cell therapy manufacturing. Established by a group of cell therapy and engineering experts with a vision of Valuing Life and Granting life-saving technologies to patients.
The ADVA X3 is a fully automated, simple, flexible, closed, and controlled manufacturing platform, for autologous cell therapies. The system efficiently manufactures therapies such as CAR-T, TCR, NK, TILs, Viruses and Exosomes. The platform controls 14 different parameters utilizing machine learning and AI, enabling a full process, from 20 million cells to 20 billion cells in one chamber, resulting in higher quality, cost efficient and decentralized manufacturing.